Merck & Co., (MRK) Gets Conditional Approval For EXZOLT CATTLE-CA1

​Merck & Co., Inc. (NYSE:MRK) is one of the Cheap NYSE Stocks to Buy Now. On December 5, an analyst from Guggenheim raised the firm’s price target on Merck & Co., Inc. (NYSE:MRK) from $104 to $122 and maintained a Buy rating on the stock. ​A day earlier, on December 4, the company announced receiving a conditional approval for EXZOLT CATTLE-CA1 from the FDA. EXZOLT CATTLE-CA1 is a topical solution containing fluralaner. The drug prevents and treats infestations caused by the New World screwworm larvae, wh ...